✨ Government Notices
1 MARCH
NEW ZEALAND GAZETTE
Economic Development
Dumping and Countervailing Duties Act 1988
Final Determination of Dumping Investigation: Tamoxifen From the United Kingdom
Pursuant to section 13 of the Dumping and Countervailing Duties Act 1988 (“the Act”), I give notice that I have made a determination that, in relation to the importation or intended importation to the goods specified in the First Schedule to this notice (“the subject goods”)—
(a) The subject goods are being dumped; but
(b) Material injury to the New Zealand industry has not been caused by reason of the subject goods being dumped.
First Schedule
Goods Subject to Determination
Country of Origin
The United Kingdom
Description of Goods
Tamoxifen Citrate (with brand name Genox) in any form or presentation.
Dated at Wellington this 21st day of February 2001.
PAUL SWAIN, Minister of Commerce.
A copy of the non-confidential version of the Final Report which contains details of the investigation and the conclusions reached, is available from the Manager, Trade Remedies Group, Ministry of Economic Development, P.O. Box 1473, Wellington.
go1485
Education
Private Schools Conditional Integration Act 1975
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
Carmel College, Milford.
The said supplementary integration agreement was executed on 22 February 2001.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the district office of the Ministry of Education, 39-45 College Hill, Ponsonby, Auckland.
Dated at Wellington this 22nd day of February 2001.
KATHY PHILLIPS, Senior Manager, National Operations.
go1446
Health
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Stocrin
Active Ingredient(s): Efavirenz 100mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from 11 November 2001.
Product: Stocrin
Active Ingredient(s): Efavirenz 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from 11 November 2001.
Product: Stocrin
Active Ingredient(s): Efavirenz 50mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from 11 November 2001.
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 23
Gazette.govt.nz —
NZ Gazette 2001, No 23
✨ LLM interpretation of page content
🏭 Final Determination of Dumping Investigation: Tamoxifen From the United Kingdom
🏭 Trade, Customs & Industry21 February 2001
Dumping, Investigation, Tamoxifen, United Kingdom, Economic Development
- PAUL SWAIN, Minister of Commerce
🎓 Supplementary Integration Agreement for Carmel College
🎓 Education, Culture & Science22 February 2001
Private Schools, Integration, Carmel College, Auckland
- KATHY PHILLIPS, Senior Manager, National Operations
🏥 Renewal of Provisional Consent to the Distribution of a New Medicine
🏥 Health & Social WelfareMedicines, Provisional Consent, Stocrin, Efavirenz, Merck Sharp & Dohme